CURC & Dr. Neal Shore Featured In USA TODAY Article On FDA Approval of Liquid Biopsy Testing
‘Coming into their own’: FDA approval of liquid biopsy tests puts early, less invasive cancer detection in broader reach Click here to read more.
Author Archive for: CURC
About CURC
This author has not written his bio yet.
But we are proud to say that CURC contributed 211 entries already.
Entries by CURC
CURC is 1st clinic in USA to include a patient in treatment in RhoVac’s clinical phase IIb study
/0 Comments/in Uncategorized/by CURCFirst patient in treatment in RhoVac’s clinical phase IIb study in the USA Click here to read more.
Results from the phase III study of nadofaregene firadenovec: Safety and efficacy in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer
/0 Comments/in Uncategorized/by CURCSpeaker: N. Shore, Myrtle Beach (US) Event: 35th Annual EAU Congress – Virtual (EAU20V) Click here to watch webcast.
Dr. Shore joins the Duke Global Health Institute Board of Advisors
/0 Comments/in Uncategorized/by CURCDr. Neal D. Shore has been invited to join the prestigious Duke Global Health Institute Board of Advisors The inaugural board of advisors for Duke Global Health Institute, founded in 2009, was composed of 14 visionary members who embraced Duke’s vision to build a world-class program that would lead its peers in the charge to […]
Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer
/0 Comments/in Uncategorized/by CURCPresented by: Neal D. Shore, Paul F. Schellhammer, Ronald F. Tutrone, Neil F. Mariados, Stacey S. Harrelson Click here to read more.
Olaparib for Metastatic Castration-Resistant Prostate Cancer- Published in The NEW ENGLAND JOURNAL of MEDICINE
/0 Comments/in Uncategorized/by CURCJohann de Bono, M.B., Ch.B., Ph.D., Joaquin Mateo, M.D., Ph.D., Karim Fizazi, M.D., Ph.D., Fred Saad, M.D., Neal Shore, M.D., Shahneen Sandhu, M.D., Kim N. Chi, M.D., Oliver Sartor, M.D., Neeraj Agarwal, M.D., David Olmos, M.D., Ph.D., Antoine Thiery-Vuillemin, M.D., Ph.D., Przemyslaw Twardowski, M.D., et al. Click here to read more.
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer- Published in The NEW ENGLAND JOURNAL of MEDICINE
/0 Comments/in Uncategorized/by CURCNeal D. Shore, M.D., Fred Saad, M.D., Michael S. Cookson, M.D., M.M.H.C., Daniel J. George, M.D., Daniel R. Saltzstein, M.D., Ronald Tutrone, M.D., Hideyuki Akaza, M.D., Alberto Bossi, M.D., David F. van Veenhuyzen, M.B., Ch.B., M.Pharm.Med., Bryan Selby, M.S., Xiaolin Fan, Ph.D., Vicky Kang, M.D., et al., for the HERO Study Investigators* Click here to […]
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer- Published in The NEW ENGLAND JOURNAL of MEDICINE
/0 Comments/in Uncategorized/by CURCPresented by: Cora N. Sternberg, M.D., Karim Fizazi, M.D., Ph.D., Fred Saad, M.D., Neal D. Shore, M.D., Ugo De Giorgi, M.D., Ph.D., David F. Penson, M.D., M.P.H., Ubirajara Ferreira, M.D., Ph.D., Eleni Efstathiou, M.D., Ph.D., Katarzyna Madziarska, M.D., Ph.D., Michael P. Kolinsky, M.D., Daniel I. G. Cubero, M.D., Ph.D., Bettina Noerby, M.D., et al., for […]
Olaparib for Metastatic Castration-Resistant Prostate Cancer
/0 Comments/in Uncategorized/by CURCPresented by: Johann de Bono, M.B., Ch.B., Ph.D., Joaquin Mateo, M.D., Ph.D., Karim Fizazi, M.D., Ph.D., Fred Saad, M.D., Neal Shore, M.D., Shahneen Sandhu, M.D., Kim N. Chi, M.D., Oliver Sartor, M.D., Neeraj Agarwal, M.D., David Olmos, M.D., Ph.D., Antoine Thiery-Vuillemin, M.D., Ph.D., Przemyslaw Twardowski, M.D., et al. Click here to read more.
SUO 2019: Overview of Clinical Research Process and Clinical Trials Structure
/0 Comments/in Uncategorized/by CURCPresented by: Neal Shore, MD, FACS, Medical Director of the Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina Click here to read more.
Contact
Carolina Urologic Research Center
823 82nd Parkway, Suite B
Myrtle Beach, SC 29572
Phone: (843) 839-1679
Fax: (843) 286-0119
Email:
info@curcmb.com
Recent Happenings
- AUA Chicago April 28 – May 1, 2023- Here We Come
- Perioperative Pembrolizumab Therapy In Muscle-Invasive Bladder Cancer: Phase III KEYNOTE-866 And KEYNOTE-905/EV-303
- Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
- Efficacy of Enzalutamide Plus Androgen Deprivation Therapy In Metastatic Hormone-Sensitive Prostate Cancer By Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
Our Affiliates
